Chapter 28 – The Role of Mast Cells, Basophils and Interleukin-3 (IL-3) in Immune Responses to Parasites: Studies with Mast Cell- and IL-3-Deficient Mice

[1]  G. Dranoff,et al.  Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites , 1998, Nature.

[2]  M. Mihm,et al.  Involvement of interleukin-3 in delayed-type hypersensitivity. , 1998, Blood.

[3]  S. Galli,et al.  IgE regulates mouse basophil Fc epsilon RI expression in vivo. , 1997, Journal of immunology.

[4]  T. Shimamura,et al.  Tumor Necrosis Factor-α– and Interleukin-6–Triggered Mast Cell Development From Mouse Spleen Cells , 1997 .

[5]  R. Mailhammer,et al.  Schistosoma mansoni infection in mice augments the capacity for interleukin 3 (IL-3) and IL-9 production and concurrently enlarges progenitor pools for mast cells and granulocytes-macrophages , 1996, Infection and immunity.

[6]  R. Nishinakamura,et al.  Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. , 1996, Blood.

[7]  Z. S. Wang,et al.  Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. , 1996, Gastroenterology.

[8]  R. Grencis,et al.  A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. , 1996, International immunology.

[9]  S. Galli,et al.  Identification of a Committed Precursor for the Mast Cell Lineage , 1996, Science.

[10]  T. Huff,et al.  Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor. , 1995, Journal of immunology.

[11]  S. Galli,et al.  Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N brasiliensis infection. , 1995, Blood.

[12]  John Malysz,et al.  W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity , 1995, Nature.

[13]  L. Lefrançois,et al.  Interactions between stem cell factor and c-Kit are required for intestinal immune system homeostasis. , 1994, Immunity.

[14]  S Torihashi,et al.  Mutation of the proto‐oncogene c‐kit blocks development of interstitial cells and electrical rhythmicity in murine intestine. , 1994, The Journal of physiology.

[15]  A. Khan,et al.  Selective effector mechanisms for the expulsion of intestinal helminths , 1994, Parasite immunology.

[16]  S. Galli,et al.  Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. , 1994, Journal of immunology.

[17]  S. Galli,et al.  Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. , 1993, The Journal of clinical investigation.

[18]  Y. Horii,et al.  Mucosal mast cells and the expulsive mechanisms of mice against Strongyloides venezuelensis. , 1993, International journal for parasitology.

[19]  M. Morimoto,et al.  Infection of Nippostrongylus brasiliensis induces normal increase of basophils in mast cell-deficient Ws/Ws rats with a small deletion at the kinase domain of c-kit , 1993 .

[20]  Y. Kitamura,et al.  Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats , 1993 .

[21]  J. Drazen,et al.  Mast cell activation enhances airway responsiveness to methacholine in the mouse. , 1993, Journal of Clinical Investigation.

[22]  S. Galli,et al.  New concepts about the mast cell. , 1993, The New England journal of medicine.

[23]  S. Nishikawa,et al.  Requirement of c-kit for development of intestinal pacemaker system. , 1992, Development.

[24]  S. Galli,et al.  The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. , 1992, Journal of immunology.

[25]  K. Austen,et al.  Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand , 1992, The Journal of experimental medicine.

[26]  K. Zsebo,et al.  Murine mast cell colony formation supported by IL‐3, IL‐4, and recombinant rat stem cell factor, ligand for c‐kit , 1991, Journal of cellular physiology.

[27]  Y. Kitamura,et al.  Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells , 1991, The Journal of experimental medicine.

[28]  M. Tsai,et al.  The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype , 1991, The Journal of experimental medicine.

[29]  S. Nishikawa,et al.  Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. , 1991, Nucleic acids research.

[30]  T. Mosmann,et al.  Interleukin 10: a novel stimulatory factor for mast cells and their progenitors , 1991, The Journal of experimental medicine.

[31]  Z. S. Wang,et al.  Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. , 1991, The Journal of clinical investigation.

[32]  David A. Williams,et al.  Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor , 1990, Cell.

[33]  B. Jakschik,et al.  The importance of mast cells for the neutrophil influx in immune complex-induced peritonitis in mice. , 1990, Journal of immunology.

[34]  J. Allen,et al.  Basophils in skin reactions of mast cell-deficient mice infested with Dermacentor variabilis. , 1990, International journal for parasitology.

[35]  V. Kindler,et al.  Interleukin 3 perfusion in W/Wv mice allows the development of macroscopic hematopoietic spleen colonies and restores cutaneous mast cell number , 1990, The Journal of experimental medicine.

[36]  K. Nocka,et al.  Molecular bases of dominant negative and loss of function mutations at the murine c‐kit/white spotting locus: W37, Wv, W41 and W. , 1990, The EMBO journal.

[37]  C. Uyttenhove,et al.  Mast cell growth‐enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9) , 1990, European journal of immunology.

[38]  S. Galli,et al.  Phorbol 12-myristate 13-acetate-induced development of functionally active mast cells in W/Wv but not Sl/Sld genetically mast cell-deficient mice. , 1990, Blood.

[39]  S. Hirota,et al.  Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. , 1990, Journal of immunology.

[40]  S. Galli,et al.  Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. , 1989, The Journal of clinical investigation.

[41]  P. Valent,et al.  The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates. , 1989, Blood.

[42]  Y. Kitamura,et al.  Substance P induces granulocyte infiltration through degranulation of mast cells. , 1989, Journal of immunology.

[43]  P. Sehgal,et al.  Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. , 1988, Science.

[44]  K. Katakura,et al.  Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Donnenberg,et al.  Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Aloe.  The effect of nerve growth factor and its antibody on mast cells in vivo , 1988, Journal of Neuroimmunology.

[47]  S. Galli,et al.  Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. , 1988, Journal of immunology.

[48]  S. Galli,et al.  125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. , 1987, Journal of immunology.

[49]  S. Galli,et al.  Development of large numbers of mast cells at sites of idiopathic chronic dermatitis in genetically mast cell-deficient WBB6F1-W/Wv mice. , 1987, Blood.

[50]  Y. Kitamura,et al.  Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. , 1987, The American journal of pathology.

[51]  R. Coffman,et al.  T-cell and mast cell lines respond to B-cell stimulatory factor 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Smith,et al.  Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Galli,et al.  Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell- deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells , 1985, The Journal of experimental medicine.

[54]  T. Suda,et al.  Proliferation and differentiation in culture of mast cell progenitors derived from mast cell‐deficient mice of genotype W/Wv , 1985, Journal of cellular physiology.

[55]  I. Hammel,et al.  Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. , 1984, Science.

[56]  K. Murrell,et al.  The intestinal mast cell response to Trichinella spiralis infection in mast cell-deficient w/wv mice. , 1984, The Journal of parasitology.

[57]  P. Cammarata,et al.  Anaphylaxis in mast cell-deficient mice. , 1984, The Journal of investigative dermatology.

[58]  J. Ihle,et al.  Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. , 1983, Journal of immunology.

[59]  M. Moore,et al.  Long-term in vitro culture of murine mast cells. III. Discrimination of mast cells growth factor and granulocyte-CSF. , 1982, Journal of immunology.

[60]  S. Galli,et al.  Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. , 1982, Journal of immunology.

[61]  H. Miller,et al.  Production and activities of IgE in helminth infection. , 1982, Progress in allergy.

[62]  J. Bell,et al.  Fused suprarenal glands in association with central nervous system defects in the first half of foetal life , 1979, The Journal of pathology.

[63]  Y. Kitamura,et al.  Decreased production of mast cells in S1/S1d anemic mice. , 1979, Blood.

[64]  Y. Kitamura,et al.  Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. , 1978, Blood.

[65]  R. Levi‐montalcini,et al.  Mast cells increase in tissues of neonatal rats injected with the nerve growth factor , 1977, Brain Research.

[66]  R. H. Jacobson,et al.  Expulsion of Nippostrongylus brasiliensis from mice lacking antibody production potential. , 1977, Immunology.

[67]  H. Dvorak,et al.  CUTANEOUS BASOPHIL HYPERSENSITIVITY : II. A LIGHT AND ELECTRON MICROSCOPIC DESCRIPTION , 1970 .

[68]  D. Rennick,et al.  Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts. , 1995, Blood.

[69]  S. Galli,et al.  The kit ligand, stem cell factor. , 1994, Advances in immunology.

[70]  W. Paul,et al.  Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro. , 1994, The American journal of pathology.

[71]  S. Galli,et al.  Effects of stem cell factor (kit-ligand) and interleukin-3 on the growth and serine proteinase expression of rat bone-marrow-derived or serosal mast cells , 1994 .

[72]  J. Ihle,et al.  Interleukin-3 and hematopoiesis. , 1992, Chemical immunology.

[73]  S. Galli,et al.  New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[74]  J. Ihle,et al.  Immunological regulation of hematopoietic/lymphoid stem cell differentiation by interleukin 3. , 1986, Advances in immunology.